The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.–3. rezultāts no 38.
29. lappuse
... activity among chemical structures not previously known to have such activity . The compounds are not simply tested at random . They are chosen from among thousands of possible structures on the basis of known activity of related ...
... activity among chemical structures not previously known to have such activity . The compounds are not simply tested at random . They are chosen from among thousands of possible structures on the basis of known activity of related ...
251. lappuse
... activity , and bears on the activity , I would certainly think that it would be a place for some claims , and probably without a showing other than the fact of the activity . Now , it is a fairly com- mon thing , as long as we are in ...
... activity , and bears on the activity , I would certainly think that it would be a place for some claims , and probably without a showing other than the fact of the activity . Now , it is a fairly com- mon thing , as long as we are in ...
699. lappuse
... activity now ascribed to them , since the sole utility disclosed in the specification was that the compounds were useful intermediates in the making of other com- pounds which had anabolic and androgenic activity . However , in In re ...
... activity now ascribed to them , since the sole utility disclosed in the specification was that the compounds were useful intermediates in the making of other com- pounds which had anabolic and androgenic activity . However , in In re ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention